|
|
|
Volumn 9, Issue 6, 2006, Pages 398-401
|
|
Histone post-translational modification: From discovery to the clinic. 7 April 2006, Southampton, UK
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 PHENYLSULFAMOYLCINNAMOHYDROXAMIC ACID;
4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID;
ACYLTRANSFERASE;
ACYLTRANSFERASE INHIBITOR;
ANILIDE;
AURORA A KINASE;
AURORA B KINASE;
CCT 046313;
CCT 075453;
CCT 077791;
DNA;
ENZYME INHIBITOR;
FR 901228;
HISTONE;
HISTONE ACETYLTRANSFERASE INHIBITOR;
HISTONE DEACETYLASE INHIBITOR;
LAQ 424;
METHYLTRANSFERASE;
METHYLTRANSFERASE INHIBITOR;
N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE;
NONHISTONE PROTEIN;
PHOSPHOTRANSFERASE;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN ARGININE METHYLTRANSFERASE;
SIRTUIN;
SULFOXIDE;
TACEDINALINE;
UCL 2007;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VORINOSTAT;
ZINC FINGER PROTEIN;
ANTINEOPLASTIC ACTIVITY;
CANCER CELL CULTURE;
CELL GROWTH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DEACETYLATION;
DNA BINDING;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
ENZYME ANALYSIS;
ENZYME SPECIFICITY;
ENZYME STRUCTURE;
GROWTH INHIBITION;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
METHYLATION;
PROTEIN MODIFICATION;
PROTEIN PROCESSING;
ZINC FINGER MOTIF;
ACETYLATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZAMIDES;
CLINICAL TRIALS;
CLINICAL TRIALS AS TOPIC;
DEPSIPEPTIDES;
HEMATOLOGIC NEOPLASMS;
HISTONE ACETYLTRANSFERASES;
HISTONE DEACETYLASE INHIBITORS;
HISTONE DEACETYLASES;
HISTONE-LYSINE N-METHYLTRANSFERASE;
HISTONES;
HUMANS;
METHYLATION;
PROTEIN CONFORMATION;
PROTEIN KINASE INHIBITORS;
PROTEIN METHYLTRANSFERASES;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
PROTEIN-SERINE-THREONINE KINASES;
QUINAZOLINES;
|
|
EID: 33745010202
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
